Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy.

Martínez-Aguilar J, Clifton-Bligh R, Molloy MP.

Sci Rep. 2016 Mar 30;6:23660. doi: 10.1038/srep23660.

2.

Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications.

Miettinen M, Kovatich AJ, Kärkkäinen P.

Virchows Arch. 1997 Dec;431(6):407-13.

PMID:
9428928
3.

Differential expression of S100C in thyroid lesions.

Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ.

Int J Surg Pathol. 2004 Apr;12(2):107-15.

PMID:
15173915
4.

Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.

Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV.

Mod Pathol. 1998 Feb;11(2):169-74.

PMID:
9504687
5.

S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma.

Ito Y, Arai K, Ryushi, Nozawa, Yoshida H, Tomoda C, Uruno T, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Kakudo K, Miyauchi A.

Pathol Res Pract. 2005;201(8-9):551-6.

PMID:
16259107
6.

Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.

Buergy D, Weber T, Maurer GD, Mudduluru G, Medved F, Leupold JH, Brauckhoff M, Post S, Dralle H, Allgayer H.

Int J Cancer. 2009 Aug 15;125(4):894-901. doi: 10.1002/ijc.24462.

7.

The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.

Montemayor-Garcia C, Hardin H, Guo Z, Larrain C, Buehler D, Asioli S, Chen H, Lloyd RV.

Endocr Pathol. 2013 Dec;24(4):206-12. doi: 10.1007/s12022-013-9272-9.

8.

[Problems in pathologic diagnosis of thyroid follicular cell carcinoma].

Li Y, Huo Z, Chen J.

Zhonghua Bing Li Xue Za Zhi. 2014 May;43(5):348-52. Review. Chinese. No abstract available.

PMID:
25030874
9.

Expression of cytokeratin 19 in cytologic specimens of thyroid.

Hirokawa M, Inagaki A, Kobayashi H, Kanahara T, Manabe T, Sonoo H.

Diagn Cytopathol. 2000 Mar;22(3):197-8. No abstract available.

PMID:
10680002
10.

Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.

Gustafson KS, LiVolsi VA, Furth EE, Pasha TL, Putt ME, Baloch ZW.

Am J Clin Pathol. 2003 Aug;120(2):175-81.

PMID:
12931546
11.

E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies.

Mitselou A, Ioachim E, Peschos D, Charalabopoulos K, Michael M, Agnantis NJ, Vougiouklakis T.

Exp Oncol. 2007 Mar;29(1):54-60.

PMID:
17431390
12.

Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.

Hermann S, Sturm I, Mrozek A, Klosterhalfen B, Hauptmann S, Dörken B, Daniel PT.

Int J Cancer. 2001 Jun 15;92(6):805-11.

13.

Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.

Kamoshida S, Ogane N, Yasuda M, Muramatsu T, Bessho T, Kajiwara H, Osamura RY.

Mod Pathol. 2000 Jul;13(7):736-41.

14.

Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.

Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O.

Mod Pathol. 1998 Aug;11(8):735-9.

PMID:
9720501
15.

Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.

Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK.

J Pathol. 2002 Oct;198(2):157-62.

16.

Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma.

Ito Y, Yoshida H, Nakano K, Kobayashi K, Yokozawa T, Hirai K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A.

Oncology. 2003;64(1):83-9.

PMID:
12457035
17.

Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.

Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.

Hum Pathol. 2008 Nov;39(11):1656-63. doi: 10.1016/j.humpath.2008.04.006. Epub 2008 Jul 26.

PMID:
18657294
18.

Nucleophosmin delocalization in thyroid tumour cells.

Pianta A, Puppin C, Passon N, Franzoni A, Romanello M, Tell G, Di Loreto C, Bulotta S, Russo D, Damante G.

Endocr Pathol. 2011 Mar;22(1):18-23. doi: 10.1007/s12022-011-9147-x.

PMID:
21258971
19.

Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue.

Serini G, Trusolino L, Saggiorato E, Cremona O, De Rossi M, Angeli A, Orlandi F, Marchisio PC.

J Natl Cancer Inst. 1996 Apr 3;88(7):442-9.

PMID:
8618236
20.

Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours.

Ruschenburg I, Vollheim B, Stachura J, Cordon-Cardo C, Korabiowska M.

Anticancer Res. 2006 May-Jun;26(3A):2107-12.

Supplemental Content

Support Center